Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
Add more filters










Database
Language
Publication year range
2.
Oral Maxillofac Surg ; 20(3): 273-9, 2016 Sep.
Article in English | MEDLINE | ID: mdl-27324749

ABSTRACT

AIM: The aim of this study is to assess the effects of triester glycerol oxide (TGO) on cutaneous wound epithelization process. MATERIAL AND METHODS: Fifty-four male Wistar rats were divided into 2 groups of 27 rats each: control(C) and TGO (PX). The groups have been divided into three subgroups which included nine rats each regarding the wound excision on the 3rd, 7th, and 10th days, respectively. The specimens were evaluated according to histological properties and hydroxyproline levels. RESULTS: Seventh day examination showed that PX and control groups present the same score. HP levels in the control group were significantly lower compared to PX groups. CONCLUSION: TGO have positive effects on wound epithelization process by increased collagen synthesis.


Subject(s)
Wound Healing/drug effects , Animals , Collagen/biosynthesis , Glycerol/pharmacology , Male , Rats , Rats, Wistar , Re-Epithelialization/drug effects
3.
Turk J Med Sci ; 45(1): 38-46, 2015.
Article in English | MEDLINE | ID: mdl-25790528

ABSTRACT

BACKGROUND/AIM: In this study, the in vitro and in vivo effectiveness of caffeic acid (3,4-dihydroxycinnamic acid) phenethyl ester (CAPE) in combination with bortezomib, a proteasome inhibitor, was explored in multiple myeloma (MM) cells. MATERIALS AND METHODS: The cytotoxic effects of CAPE and bortezomib were determined by XTT cell proliferation assay. Apoptosis levels were analyzed with annexin V-fluorescein isothiocyanate, nuclear factor kappa beta (NF-κB) was analyzed with electrophoretic mobility-shift assay, and interleukin (IL)-6 levels were analyzed with enzyme-linked immunosorbent assay to evaluate CAPE's mechanism of action. To investigate the in vivo effectiveness of CAPE and bortezomib, an experimental plasmacytoma model was induced in BALB/c mice. RESULTS: Increasing concentrations of CAPE and bortezomib decreased the proliferation of ARH-77 cells in a dose-dependent manner. With doses of CAPE IC50, a significant increase in apoptosis and a significant decrease in IL-6 levels were detected. The NF-κB DNA- binding activity decreased compared to the basal ARH-77 level. The administration of CAPE alone or in combination with bortezomib increased the rate of survival compared to the control group. CONCLUSION: We think that our study, which is the first to demonstrate the in vitro and in vivo effectiveness of the.combined use of CAPE and bortezomib, will be a pioneer for future human applications of CAPE in MM.


Subject(s)
Antineoplastic Agents/pharmacology , Boronic Acids/pharmacology , Caffeic Acids/pharmacology , Cell Survival/drug effects , Multiple Myeloma , Phenylethyl Alcohol/analogs & derivatives , Pyrazines/pharmacology , Animals , Apoptosis/drug effects , Bortezomib , Cell Line, Tumor , Cell Proliferation/drug effects , Dose-Response Relationship, Drug , Female , Humans , Interleukin-6/metabolism , Mice , Mice, Inbred BALB C , NF-kappa B/metabolism , Phenylethyl Alcohol/pharmacology , Survival Analysis
4.
Adv Clin Exp Med ; 21(4): 441-6, 2012.
Article in English | MEDLINE | ID: mdl-23240449

ABSTRACT

BACKGROUND: Unfavorable effects of in-utero smoke exposure have been shown in several studies. OBJECTIVES: In this experimental study, the authors aimed at showing detrimental effects of cigarette smoke on fetal tissues by assessing apoptosis that is detected by performing TUNEL staining. MATERIAL AND METHODS: Designed groups were smoke exposed rats before and during pregnancy and control groups. Rat offsprings were sacrificed when they were 12 days old. RESULTS: Lung, kidney, adrenal and gonad tissues were harvested for histopathologic analysis and assessed by TUNEL (Terminal dUTP Nick End Labeling) staining. CONCLUSIONS: Smoke exposure caused increased apoptotic activity in lung parenchyma of study groups.


Subject(s)
Maternal Exposure , Smoking , Animals , Apoptosis , Female , In Situ Nick-End Labeling , Pregnancy , Rats
5.
Acta Neurochir Suppl ; 110(Pt 2): 81-5, 2011.
Article in English | MEDLINE | ID: mdl-21125450

ABSTRACT

BACKGROUND: the aim of this study was to assess and to compare the ability of intrathecal nicergoline and nimodipine in prevention of cerebral vasospasm in a rabbit model of subarachnoid hemorrhage (SAH). METHOD: twenty male New Zealand white rabbits were allocated into four groups randomly. Subarachnoid hemorrhage was induced by injecting autologous blood into the cisterna magna. The treatment groups were as follows: (1) control [no SAH (n = 5)], (2) SAH only (n = 5), (3) SAH plus nimodipine (n = 5), and (4) SAH plus nicergoline (n = 5). FINDINGS: there was a statistically significant difference between the mean basilar artery cross-sectional areas and the mean arterial wall thickness measurements of the control and SAH-only groups (p < 0.05). Basilar artery vessel diameter and luminal section areas in group 3 were significantly higher than in group 2 (p < 0.05). Basilar artery vessel diameter and basilar artery luminal section areas in group 4 were significantly higher than in group 2 (p < 0.05). There was no significant difference between basilar artery vessel diameter and basilar artery luminal section areas in group 3 and group 4. CONCLUSIONS: these findings demonstrate that intrathecal nicergoline has a vasodilatatory effect in an experimental model of SAH in rabbits but not more than that of nimodipine.


Subject(s)
Adrenergic alpha-Antagonists/therapeutic use , Calcium Channel Blockers/therapeutic use , Nicergoline/therapeutic use , Nimodipine/therapeutic use , Vasospasm, Intracranial/drug therapy , Angiography, Digital Subtraction/methods , Animals , Basilar Artery/diagnostic imaging , Basilar Artery/drug effects , Basilar Artery/pathology , Disease Models, Animal , Injections, Spinal/methods , Male , Neurologic Examination , Rabbits , Subarachnoid Hemorrhage/complications , Vasospasm, Intracranial/diagnostic imaging , Vasospasm, Intracranial/etiology
6.
Am J Emerg Med ; 27(4): 409-12, 2009 May.
Article in English | MEDLINE | ID: mdl-19555609

ABSTRACT

PURPOSE: Acute appendicitis is one of the most common surgical emergencies. Diagnosis is usually made depending on the presenting history, clinical evaluation, and laboratory tests. The aim of this study was to investigate the role of urinary 5-hydroxyindoleacetic acid (U-5-HIAA) in the early diagnosis of acute appendicitis. METHODS: Thirty-five pigmented male rabbits were divided into 5 groups. Group 1 is the control (n = 7); group 2 is the sham (n = 10). The appendix was ligated from its base, and an appendectomy was performed after 12, 24, 36 hours in group 3 (n = 7), group 4 (n = 7), and group 5 (n = 7), respectively. Spot urine samples were obtained for U-5-HIAA determination, and appendectomy tissues were examined histopathologically. RESULTS: Acute appendicitis was diagnosed in all animals in group 3, group 4, and group 5, and the mean levels of U-5-HIAA in group 3 were higher than in the other groups. The mean of U-5-HIAA levels between animals with appendicitis and those without showed a significant difference (P = .003). The U-5-HIAA cutoff point of 4.15 mg/g creatinine had a sensitivity of 85%, a specificity of 64.29%, and an accuracy of 76% (area under curve = 0.805) for acute appendicitis. The probability of acute appendicitis is found to be 10, 2 times more when the U-5-HIAA level is greater than 4.15 mg/g creatinine. CONCLUSION: We have concluded that spot U-5-HIAA level increases significantly in the early stages of acute appendicitis.


Subject(s)
Appendicitis/diagnosis , Hydroxyindoleacetic Acid/urine , Acute Disease , Animals , Appendicitis/pathology , Appendicitis/urine , Early Diagnosis , Male , Rabbits , Sensitivity and Specificity
7.
Age (Dordr) ; 31(1): 39-49, 2009 Mar.
Article in English | MEDLINE | ID: mdl-19234767

ABSTRACT

Increased serum insulin levels and reduced peripheral insulin activities seen in insulin resistance syndrome are associated with age-dependent cognitive impairment and Sporadic Alzheimer's Disease (SAD), suggesting a disturbance in the insulin signalling system in the brain and possibly being one of the causes of dementia. Therefore, the streptozotocin (STZ)-induced animal may be an appropriate model for the investigation of SAD and related dementia. This study was designed to investigate the beneficial effect of Curcumin (CUR), a neuroprotective agent, on intracerebroventricular (ICV) STZ-induced cognitive impairment in rats. For this purpose, adult male Wistar rats were bilaterally ICV injected with STZ (3 mg/kg). An artificial cerebrospinal fluid (aCSF) was given to the control group (SHAM) instead of STZ on days 1 and 3. Learning and memory performance were assessed using the "passive avoidance task" and the "Morris water maze test". After confirmation of acquisition impairment with these tests, the STZ group was divided into two subgroups: STZ + vehicle (Vh) and STZ + CUR. The rats in the SHAM and STZ + Vh groups were administered intraperitoneally with 0.5 ml Vh and the rats in the STZ + CUR group were treated intraperitoneally with CUR (300 mg kg(-1) day(-1) in Vh) for 10 days starting from the 25th day after STZ injection. The Morris water maze test was reapplied on the 35th day after STZ injection and all of the rats were sacrificed on day 36 for quantitation of IGF-1 and for histopathological evaluation. Rats in the STZ + CUR group were found to have a higher performance in cognitive tests than rats in the STZ + Vh group (P < 0.01). In parallel with the cognitive tests, IGF-1 levels were decreased in all of the STZ-injected groups (1.78 +/- 0.34) compared to the SHAM group (3.46 +/- 0.41). In contrast, CUR treatment significantly increased IGF-1 levels (P < 0.001). The degree of neuronal loss decreased after CUR treatment compared to the SHAM group (P < 0.02). These results clearly indicate that CUR treatment is effective in reducing the cognitive impairment caused by STZ in rats, and may be a potential therapeutic agent for altering neurodegeneration in SAD.

8.
J Med Case Rep ; 2: 62, 2008 Feb 26.
Article in English | MEDLINE | ID: mdl-18302769

ABSTRACT

INTRODUCTION: Tuberculosis of the parotid gland is a rare clinical entity which causes some difficulties in diagnosis because of the similarities in presentation to that of a neoplasm. Diagnosis mainly relies in the treating physician having a high index of suspicion. The diagnosis is generally overlooked by otolaryngologists and most cases are undergoing unnecessary surgery. CASE PRESENTATION: A 20-year-old male presented with a mass in the right parotid region. The mass had been present for one year. Physical examination revealed a mobile, non-tender mass occupying the superficial lobe of the right parotid gland. Radiologic investigations revealed a well-defined, solid, mass lesion located in the posterior part of the superficial lobe of the right parotid gland. A provisional diagnosis of a neoplasm of the parotid gland was made and a right superficial parotidectomy was performed. Histopathologic examination of the specimen was reported as tuberculosis of the parotid gland. The patient was commenced on antitubercular chemotherapy. CONCLUSION: Although rare, tuberculosis should be kept in mind and considered in the differential diagnosis of patients presenting with a solitary tumor in the parotid gland in order to avoid unnecessary surgery.

9.
J Laryngol Otol ; 120(1): 70-3, 2006 Jan.
Article in English | MEDLINE | ID: mdl-16359152

ABSTRACT

Hamartomas of the cerebellopontine angle or internal auditory canal are very rare and only four cases have been reported. We report an unusual case of a glioneural hamartoma of the VIIIth nerve with clinical, radiological and audiometric similarity with vestibular schwannoma.


Subject(s)
Hamartoma/diagnosis , Vestibulocochlear Nerve Diseases/diagnosis , Adult , Craniotomy/methods , Ear, Inner/pathology , Hamartoma/pathology , Hamartoma/surgery , Humans , Magnetic Resonance Imaging/methods , Male , Temporal Bone , Treatment Outcome , Vestibulocochlear Nerve Diseases/pathology , Vestibulocochlear Nerve Diseases/surgery
SELECTION OF CITATIONS
SEARCH DETAIL
...